Modelo PTZ: Un screening primario para el desarrollo de nuevas moléculas con actividad anticonvulsivante

F. R. Ramos-Morales, J. Correa-Basurto, M. Saavedra-Vélez, M. E. Acosta-Hernández, E. Gasca-Pérez, A. Pérez-Palacios, J. Trujillo-Ferrara

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

3 Citas (Scopus)

Resumen

Epilepsy is a chronic disease which is defined by a set of neurological disorders that leaves a high predisposition in the brain to recurrent seizures. While no cure for this brain disorder, however, are used for treatment drugs that inhibit the biochemical mechanisms called anticonvulsants. This make important the need to use animal models to study this disease, as well as, the development and discovery of new drugs, they provide the basics for understanding the mechanisms of disease and are suitable for studying mechanisms of induction of seizures. Within these models stands the model of chemically induced by pentylenetetrazole, which, of its low cost and easy handling is widely used in drug discover y and development of anticonvulsants.

Título traducido de la contribuciónModel PTZ primary screening for the development of new molecules with anticonvulsantactivity
Idioma originalEspañol
Páginas (desde-hasta)22-25
Número de páginas4
PublicaciónArchivos de Neurociencias
Volumen17
N.º1
EstadoPublicada - ene. 2012

Palabras clave

  • Animal models
  • Epilepsy
  • Pentylenetetrazole

Huella

Profundice en los temas de investigación de 'Modelo PTZ: Un screening primario para el desarrollo de nuevas moléculas con actividad anticonvulsivante'. En conjunto forman una huella única.

Citar esto